Sterling Medivations receives nine FDA approvals for diabetes products

Sterling Medivations, Inc., provider of unique insulin infusion solutions for people with diabetes, recently announced that it has received nine FDA 510K approvals within the past six months for its insulin pump catheters and unique Silver Pen and LifeMatch System insulin infusion devices.

Sterling's founders, who have a collective 25 years as established leaders in the development of diabetes products, are creating new opportunities for people with diabetes to deal with the everyday challenges of their disease and creating additional market opportunities for the product retailers and distributors who serve them.

Sterling Medivations co-founder and CEO Joel Douglas, says, "Sterling Medivations' mission is to be the leader in providing innovative, simple, low cost, and convenient solutions for the insulin infusion marketplace. We pride ourselves in our dedication and our passion to serving our customers with dignity, and effective solutions."

The following details some of the innovative devices that underscore Sterling's reputation as spearheading the evolution of diabetes devices to enhance the diabetic's quality of life:

1. Sterling's Silver Pen, a new insulin injection device approved in December 2000, with its unique form and function, provides the person with diabetes substantially enhanced comfort and safety not available with other reusable insulin pens.

2. Approved in April 2001, the Sterling Simplicity line of catheters can now be coupled with the Silver Pen to provide, for the first time, the benefits of catheter use, previously available only to insulin pump users, to the 4.5 million people with diabetes whose only choice for injection has been traditional insulin pens and syringes. Dubbed The LifeMatch System, this combination allows people with diabetes to simply and discreetly push a plunger on the small pager-like device and directly inject their insulin through the hidden catheter without the necessity of leaving a meeting or social event to prepare and inject with a syringe or traditional pen. More frequent insulin injections have been shown by several clinical trials to lead to better disease control, and the privacy and convenience of LifeMatch, with resulting improved disease management, will make it a favorite of both people with diabetes and their health care providers.

3. With the approval of Sterling's new line of Simple Choice Soft and Winged style catheters, people with diabetes will, for the first time, be able to purchase their insulin infusion catheters, previously available only from insulin pump makers, direct from their local pharmacies and drug retailers. Sterling's catheters, compatible with all current insulin pumps, will now be conveniently available at local pharmacies and will offer the user substantial price reductions and the retailer new opportunities to serve a new class of customer.

4. In addition to Sterling's Soft and Winged style catheters, Silver Pen and LifeMatch, Sterling has now developed and obtained FDA approval for its innovative new line of catheters, the Sterling Y Catheters. With the Sterling Y, the user will now, for the first time, be able to use both an insulin pump catheter and traditional syringes and insulin pens, at the same time, without multiple painful "sticks" or injections.

5. Rounding out the new line-up is the Sterling Infuser. Inserted every two to three days like a catheter, the Infuser, without tubes or pumps, allows persons such as children who need help with their injections, or users who simply prefer a syringe or pen, to inject their insulin without multiple, painful "sticks."

Sterling's robust growth mode includes the establishment of a manufacturing alliance with one of the leading manufacturers of diabetes products in the U.S. and Japan. Sterling has also established a marketing partnership with a major U.S. supplier of diabetes infusion products, and they are in final negotiations with a major Euro/Asian distributor. In addition, they are actively seeking marketing alliances and partnerships with other diabetes suppliers, major retailers and distributors nationwide.

About Sterling Medivations
Sterling's founders have more than 25 years of experience with diabetes products and devices and have managed and taken public, start-up companies in this arena. They founded Sterling Medivations with the express mission of bringing innovative insulin infusion solutions to the diabetes market and to the 4.6 million people who need daily insulin injections. Sterling raised its first round of venture capital in July 2000 and is in the process of raising the second round this spring. The "Sterling Model" includes the design, development and protection of innovative infusion solutions coupled with leveraging the manufacturing infrastructure of established product manufacturers. This, together with Sterling's strategy of building marketing alliances with established retailers and distributors will allow Sterling to become a dominant force in the market in 2001 and beyond. For more information on Sterling and its products see www.sterlingmedivations.com, or email us at info@sterlingmedivations.com, or call 408.297.9473, ext. 0.

Source: Sterling Medivations

---

Subscribe to our free e-mail newsletter.

Click for a free Buyer's Guide listing.